3.05
前日終値:
$3.11
開ける:
$3.09
24時間の取引高:
114.29K
Relative Volume:
0.23
時価総額:
$191.46M
収益:
$163.78M
当期純損益:
$25.88M
株価収益率:
4.6923
EPS:
0.65
ネットキャッシュフロー:
$-28.66M
1週間 パフォーマンス:
+1.33%
1か月 パフォーマンス:
+10.95%
6か月 パフォーマンス:
-46.38%
1年 パフォーマンス:
-61.32%
Voyager Therapeutics Inc Stock (VYGR) Company Profile
名前
Voyager Therapeutics Inc
セクター
電話
857-259-5340
住所
75 HAYDEN AVENUE, LEXINGTON, MA
VYGR を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
VYGR
Voyager Therapeutics Inc
|
3.05 | 191.46M | 163.78M | 25.88M | -28.66M | 0.65 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
450.20 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
534.90 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
321.24 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
558.17 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
242.62 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-01-10 | 開始されました | Cantor Fitzgerald | Overweight |
2024-12-02 | 開始されました | Citigroup | Buy |
2024-11-29 | 再開されました | Wedbush | Outperform |
2024-10-16 | 開始されました | Leerink Partners | Outperform |
2024-03-26 | 開始されました | Guggenheim | Buy |
2024-03-19 | 開始されました | H.C. Wainwright | Buy |
2024-03-07 | 開始されました | Citigroup | Buy |
2024-01-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2023-05-10 | 開始されました | Truist | Buy |
2023-03-10 | 開始されました | Oppenheimer | Outperform |
2021-10-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
2021-02-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2021-02-03 | ダウングレード | BTIG Research | Buy → Neutral |
2021-02-03 | ダウングレード | Wedbush | Outperform → Neutral |
2020-12-24 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2020-12-23 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2020-11-11 | ダウングレード | Oppenheimer | Outperform → Perform |
2020-11-10 | ダウングレード | Raymond James | Strong Buy → Outperform |
2020-11-10 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2020-03-19 | 開始されました | The Benchmark Company | Buy |
2020-02-06 | 開始されました | Oppenheimer | Outperform |
2018-11-15 | アップグレード | Raymond James | Outperform → Strong Buy |
2018-09-10 | 再開されました | BTIG Research | Buy |
2018-09-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2018-06-04 | 開始されました | H.C. Wainwright | Buy |
2018-03-12 | ダウングレード | Evercore ISI | Outperform → In-line |
2018-03-12 | ダウングレード | Wedbush | Outperform → Neutral |
2018-02-02 | 開始されました | Morgan Stanley | Overweight |
2017-11-28 | 再開されました | Piper Jaffray | Overweight |
2017-10-31 | 開始されました | Robert W. Baird | Outperform |
2017-10-27 | 開始されました | Canaccord Genuity | Buy |
2017-10-23 | 繰り返されました | Stifel | Buy |
2017-10-12 | 開始されました | Raymond James | Outperform |
2017-08-17 | 開始されました | Evercore ISI | Outperform |
2017-07-28 | 再開されました | Stifel | Buy |
すべてを表示
Voyager Therapeutics Inc (VYGR) 最新ニュース
Financial Comparison: Prime Medicine (NYSE:PRME) & Voyager Therapeutics (NASDAQ:VYGR) - Defense World
Voyager Therapeutics at H.C. Wainwright: Genetic Innovation in Focus By Investing.com - Investing.com Canada
Equities Analysts Offer Predictions for VYGR FY2026 Earnings - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspecti - GuruFocus
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference | VYGR Stock News - GuruFocus
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewswire
Millennium Management LLC Sells 60,935 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Squarepoint Ops LLC Decreases Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics: Navigating AAV Headwinds And A Long Road For VY7523 (Downgrade) - Seeking Alpha
Voyager Therapeutics Approves Stock Plans at Annual Meeting - TipRanks
BNP Paribas Financial Markets Sells 43,210 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Holdings Lowered by ProShare Advisors LLC - Defense World
Deutsche Bank AG Cuts Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Jane Street Group LLC - Defense World
Voyager Therapeutics stock plunges to 52-week low of $2.71 By Investing.com - Investing.com South Africa
Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates - MSN
Voyager Therapeutics stock plunges to 52-week low of $2.71 - Investing.com
It's Unlikely That The CEO Of Voyager Therapeutics, Inc. (NASDAQ:VYGR) Will See A Huge Pay Rise This Year - simplywall.st
Northern Trust Corp Raises Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
With 46% ownership, Voyager Therapeutics, Inc. (NASDAQ:VYGR) has piqued the interest of institutional investors - Yahoo Finance
Cubist Systematic Strategies LLC Buys New Shares in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Tower Research Capital LLC TRC Increases Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Brokerages - Defense World
Voyager Therapeutics (VYGR) Showcases Breakthrough in Gene Thera - GuruFocus
Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain - GlobeNewswire
Revolutionary Brain Drug Delivery: Voyager's New Gene Therapy Shows 400x Improvement in Landmark Research - Stock Titan
Voyager reports breakthrough in brain drug delivery - Investing.com
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Voyager Therapeutics (VYGR) and Privia Health Group (PRVA) - The Globe and Mail
Q2 EPS Forecast for Voyager Therapeutics Reduced by Analyst - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock Position Increased by Dimensional Fund Advisors LP - Defense World
FY2025 EPS Estimates for VYGR Increased by Cantor Fitzgerald - Defense World
Leerink Partnrs Has Negative Outlook of VYGR Q2 Earnings - Defense World
Q2 EPS Estimates for Voyager Therapeutics Lifted by Wedbush - Defense World
Voyager Therapeutics Reports Q1 2025 Financial Results - TipRanks
Barclays PLC Buys 10,328 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Analysts Have Conflicting Sentiments on These Healthcare Companies: Omnicell (OMCL), Voyager Therapeutics (VYGR) and Masimo (MASI) - The Globe and Mail
Voyager Therapeutics Inc earnings missed by $0.08, revenue fell short of estimates - Investing.com India
Raymond James Financial Inc. Takes $746,000 Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics: Q1 Earnings Snapshot - Connecticut Post
Voyager Reports First Quarter 2025 Financial and Operating Results - The Manila Times
Voyager Therapeutics Q1 2025 Financial and Operating Results - TradingView
Voyager Therapeutics, Inc. SEC 10-Q Report - TradingView
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Renaissance Technologies LLC - Defense World
Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer - Stock Titan
BlackRock, Inc. Reduces Stake in Voyager Therapeutics Inc - GuruFocus
Voyager Therapeutics Inc (VYGR) 財務データ
収益
当期純利益
現金流量
EPS
Voyager Therapeutics Inc (VYGR) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Sandrock Alfred | President and CEO |
Apr 02 '25 |
Sale |
3.43 |
10,885 |
37,336 |
430,931 |
大文字化:
|
ボリューム (24 時間):